(Q43702784)

English

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Shih-Wei Lai

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Pei-Chun Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Kuan-Fu Liao

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Chih-Hsin Muo

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Cheng-Chieh Lin

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Fung-Chang Sung

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

language of work or name

0 references

publication date

15 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

46-52

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

https://scigraph.springernature.com/pub.10.1038/ajg.2011.384

0 references

Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Non-viral causes of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Diabetes and cancer: a consensus report.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Community-Based Epidemiological Study on Diabetes in Pu-Li, Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Inability of waist-to-height ratio to predict new onset diabetes mellitus among older adults in Taiwan: a five-year observational cohort study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Neither diabetes mellitus nor overweight is a risk factor for hepatocellular carcinoma in a dual HBV and HCV endemic area: community cross-sectional and case-control studies

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Metformin and other biguanides in oncology: advancing the research agenda

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Long-term metformin use is associated with decreased risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Diagnosis and Treatment of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Hepatocellular carcinoma development in cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.384

21 January 2018

Identifiers

10.1038/AJG.2011.384

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43702784&oldid=2102691453"